TY  - JOUR
AU  - Onecha. Esther
AU  - Linares Gómez, María
AU  - Rapado, Inmaculada
AU  - Ruiz-Heredia, Yanira
AU  - Martínez Sánchez, María Del Pilar
AU  - Cedena Romero, M. Teresa
AU  - Pratcorona, Marta
AU  - Perez Oteyza, Jaime
AU  - Herrera, Pilar
AU  - Barragan, Eva
AU  - Montesinos, Pau
AU  - Garcia Vela, Jose Antonio
AU  - Magro, Elena
AU  - Anguita Mandly, Eduardo Luis
AU  - Figuera, Angela
AU  - Riaza, Rosalia
AU  - Martínez Barranco, María Pilar
AU  - Sanchez-Vega, Beatriz
AU  - Nomdedeu, Josep
AU  - Gallardo, Miguel
AU  - Ayala Díaz, Rosa María
AU  - Martínez López, Joaquín
PY  - 2019
DO  - 10.3324/haematol.2018.194712
SN  - 0390-6078
UR  - https://hdl.handle.net/20.500.14352/93581
T2  - Haematologica
AB  - A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. We designed and validated a...
LA  - eng
M2  - 288
PB  - Ferrata Storti Foundation
TI  - A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
TY  - journal article
VL  - 104
ER  -